ArticleFrontiers in oncology2021

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report.

Verena Nilius-Eliliwi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.